to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Medical device startups and other life science companies are receiving funding from the GE Healthymagination Fund. Read more about how the fund works.
Late-stage deals don't have much value for one outspoken venture capitalist. Read more about the reasons for his claim.
Venture capital investment by corporations in the healthcare sector fell in the first quarter, but that may improve since the Affordable Care Act was upheld. Read more about investments in the healthcare sector.
Venture capital funding declined in the second quarter for the life sciences sector. Read more about how medical device startups and biotech companies fared.
Entrepreneurs could give their budding companies a powerful financial boost by using a source of funding usually considered off limits--the retirement kitty. The author, a certified financial planner, does, however, caution company builders to leave a portion of those funds intact, using more accessible sources first. Thereafter, he argues, tax-deferred assets in a 401(k), SEP, or IRA comprise a personal venture capital fund that can do as much for an individual's business as for his or her golden years.
Venture funding is up, albeit slightly. To grab your slice of the capital pie, start thinking differently.
The most promising incubators for young healthcare entrepreneurs are U.S. colleges and universities. Case in point? Wake Forest and its “Business Elevator” competition.
Healthcare stocks are just what the doctor ordered when it comes to a tough economy – at least, that’s the opinion of one investment guru.
Two leading academics are out with a new book that says the key to making money for new business owners is this: your financial statements are your friends.
It’s no secret that the economy is in sickbay. But healthcare entrepreneurs looking for a big transfusion of cash shouldn’t look to an initial public offering.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.